Cite
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients
MLA
Piccaluga, Pier Paolo, et al. “First Experience with Gemtuzumab Ozogamicin plus Cytarabine as Continuous Infusion for Elderly Acute Myeloid Leukaemia Patients.” Leukemia Research, vol. 28, no. 9, Sept. 2004, pp. 987–90. EBSCOhost, https://doi.org/10.1016/j.leukres.2004.01.009.
APA
Piccaluga, P. P., Martinelli, G., Rondoni, M., Malagola, M., Gaitani, S., Visani, G., & Baccarani, M. (2004). First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients. Leukemia Research, 28(9), 987–990. https://doi.org/10.1016/j.leukres.2004.01.009
Chicago
Piccaluga, Pier Paolo, Giovanni Martinelli, Michela Rondoni, Michele Malagola, Stavroula Gaitani, Giuseppe Visani, and Michele Baccarani. 2004. “First Experience with Gemtuzumab Ozogamicin plus Cytarabine as Continuous Infusion for Elderly Acute Myeloid Leukaemia Patients.” Leukemia Research 28 (9): 987–90. doi:10.1016/j.leukres.2004.01.009.